108 related articles for article (PubMed ID: 6456216)
1. Fibrinogen degradation by two neutral granulocyte proteinases. Influence of calcium on the generation of fibrinogen degradation products with anticlotting properties.
Bingenhkeimer C; Gramse M; Egbring R; Havemann K
Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):853-63. PubMed ID: 6456216
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
[TBL] [Abstract][Full Text] [Related]
3. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
Ney KA; Pizzo SV
Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y).
Nieuwenhuizen W; Voskuilen M; Hermans J
Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte enzyme mediated degradation of human fibrinogen in plasma in vitro.
Sterrenberg L; Gravesen M; Haverkate F; Nieuwenhuizen W
Thromb Res; 1983 Sep; 31(5):719-28. PubMed ID: 6557687
[TBL] [Abstract][Full Text] [Related]
7. Demonstration and semiquantitative determination of complexes between various proteases and human alpha2-macroglobulin.
Ohlsson K; Skude G
Clin Chim Acta; 1976 Jan; 66(1):1-7. PubMed ID: 177230
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anticlotting activity of fragments D formed during plasmin hydrolysis of fibrinogen in the presence of calcium chloride.
Belitser VA; Varetska TV; Tolstykh VM; Tsaryuk LA; Pozdnyakova TM
Thromb Res; 1975 Nov; 7(5):797-806. PubMed ID: 128845
[No Abstract] [Full Text] [Related]
9. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X).
Nieuwenhuizen W; Gravesen M
Biochim Biophys Acta; 1981 Mar; 668(1):81-8. PubMed ID: 6453618
[TBL] [Abstract][Full Text] [Related]
10. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
11. Degradation of human fibrinogen by chymotrypsin-like neutral protease from human granulocytes.
Gramse M; Bingenheimer C; Havemann K
Thromb Res; 1980 Jul 1-15; 19(1-2):201-9. PubMed ID: 6160637
[No Abstract] [Full Text] [Related]
12. A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme.
Feinstein G; Janoff A
Biochim Biophys Acta; 1975 Oct; 403(2):477-92. PubMed ID: 1081003
[TBL] [Abstract][Full Text] [Related]
13. The effect of human granulocyte proteinases on kininogens.
Dittman B; Wimmer R; Mindermann R; Ohlsson K
Adv Exp Med Biol; 1979; 120B():297-304. PubMed ID: 229706
[TBL] [Abstract][Full Text] [Related]
14. [Fibrinogen split products of neutral proteases from human granulocytes; characterization and effect on in vitro blood coagulation].
Gramse M; Bingenheimer C; Egbring R; Havemann K
Verh Dtsch Ges Inn Med; 1978; (84):1353-6. PubMed ID: 741965
[No Abstract] [Full Text] [Related]
15. Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors.
Schmidt W; Egbring R; Havemann K
Thromb Res; 1975 Apr; 6(4):315-29. PubMed ID: 1079636
[No Abstract] [Full Text] [Related]
16. [Direct proteolysis of coagulation factors through granulocyte enzymes as a possible mechanism of blood coagulation disorders in acute leukemia and septicemia].
Egbring R; Schmidt W; Havemann K
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1629-32. PubMed ID: 1030064
[No Abstract] [Full Text] [Related]
17. Purification and partial characterization of a D-like fragment from human fibrinogen, produced by human leukocyte elastase.
Sterrenberg L; Nieuwenhuizen W; Hermans J
Biochim Biophys Acta; 1983 Jan; 755(2):300-6. PubMed ID: 6550499
[TBL] [Abstract][Full Text] [Related]
18. Sbustrate specificity of the elastase and the chymotrypsin-like enzyme of the human granulocyte.
Zimmerman M; Ashe BM
Biochim Biophys Acta; 1977 Jan; 480(1):241-5. PubMed ID: 401649
[TBL] [Abstract][Full Text] [Related]
19. Human inter-alpha-trypsin inhibitor. Limited proteolysis by trypsin, plasmin, kallikrein and granulocytic elastase and inhibitory properties of the cleavage products.
Dietl T; Dobrinski W; Hochstrasser K
Hoppe Seylers Z Physiol Chem; 1979 Sep; 360(9):1313-8. PubMed ID: 92450
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin.
Ohlsson K; Collen D
Scand J Clin Lab Invest; 1977 Jun; 37(4):345-50. PubMed ID: 210494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
